Literature DB >> 15585307

Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine.

Hitoshi Ohmori1, Michio Oka, Yumiko Nishikawa, Hiroyuki Shigemitsu, Masahiro Takeuchi, Masaki Magari, Naoki Kanayama.   

Abstract

To explore the link between inflammation and autoimmunity, we analyzed the immunogenicity of 3-nitrotyrosine (NT)-bearing self-proteins, an inflammation-associated marker that is formed by nitration of protein tyrosine residues with peroxynitrite generated during inflammation. An interesting feature of NT is its structural similarity to a synthetic hapten, 4-hydroxy-3-nitrophenylacetyl (NP), with which some anti-DNA antibodies (Abs) have been reported to show cross-reactivity. We confirmed that some of anti-DNA monoclonal Abs (mAbs) obtained from MRL/lpr mice also bound NT as well as NP. Based on these findings, we examined whether NT-bearing autologous IgG (NT-IgG) as a model of NT-self proteins is immunogenic to induce a DNA-cross-reactive anti-NT Ab response in autologous normal mice. Anti-NT IgM and IgG Ab responses were elicited after the third immunization with NT-IgG, concomitant with an increase in anti-single stranded (ss)DNA titer. Interestingly, a part of anti-NT mAbs thus induced showed cross-reactivity with ssDNA, some of which used VH sequences that were highly homologous to those reported in anti-DNA Abs from NZB/WF1 mice. Splenic T cells primed with NT-IgG, but not with unmodified IgG, showed a proliferative response to the inducing antigen. Collectively, NT-IgG is immunogenic in autologous hosts, and can induce anti-NT Abs that are cross-reactive with ssDNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585307     DOI: 10.1016/j.imlet.2004.07.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.

Authors:  Vincent J Venditto; Douglas S Watson; Michael Motion; David Montefiori; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

Review 2.  Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide.

Authors:  Andrea Predonzani; Bianca Calì; Andrielly Hr Agnellini; Barbara Molon
Journal:  World J Exp Med       Date:  2015-05-20

Review 3.  The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates; Gary S Gilkeson
Journal:  Clin Immunol       Date:  2006-07-24       Impact factor: 3.969

4.  Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.

Authors:  Vincent J Venditto; Lindsay Wieczorek; Sebastian Molnar; Fernando Teque; Gary Landucci; Douglas S Watson; Donald Forthal; Victoria R Polonis; Jay A Levy; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

Review 5.  Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus.

Authors:  Rizwan Ahmad; Haseeb Ahsan
Journal:  Clin Exp Med       Date:  2012-11-23       Impact factor: 3.984

6.  Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations.

Authors:  Rory C Monahan; Michelle D van den Beukel; Nicole V Borggreven; Rolf Fronczek; Tom W J Huizinga; Margreet Kloppenburg; Gerda M Steup-Beekman; Leendert A Trouw
Journal:  RMD Open       Date:  2022-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.